Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Tawil

Showing results (21-30 of 40) with videos related to

Pageof 4
Sort By:
Neurology|October 24, 2001
Randomized, double-blind, placebo-controlled trial of albuterol in facioscapulohumeral dystrophyJ T Kissel, M P McDermott, J R Mendell, et al.
Annals of Neurology|June 1, 1996
Evidence for anticipation and association of deletion size with severity in facioscapulohumeral muscular dystrophy. The FSH-DY GroupR Tawil, J Forrester, R C Griggs, et al.
Annals of Neurology|March 1, 1994
Andersen's syndrome: potassium-sensitive periodic paralysis, ventricular ectopy, and dysmorphic featuresR Tawil, L J Ptacek, S G Pavlakis, et al.
Neurology|May 22, 1998
Pilot trial of albuterol in facioscapulohumeral muscular dystrophy. FSH-DY GroupJ T Kissel, M P McDermott, R Natarajan, et al.
Cell|December 9, 1991
Identification of a mutation in the gene causing hyperkalemic periodic paralysisL J Ptácek, A L George, R C Griggs, et al.
Nature Genetics|June 1, 1993
Mapping the facioscapulohumeral muscular dystrophy gene is complicated by chromsome 4q35 recombination eventsB Weiffenbach, J Dubois, D Storvick, et al.
Brain : a Journal of Neurology|October 1, 2005
The primary periodic paralyses: diagnosis, pathogenesis and treatmentS L Venance, S C Cannon, D Fialho, et al.
Neurology|August 1, 1994
Sodium channel mutations in acetazolamide-responsive myotonia congenita, paramyotonia congenita, and hyperkalemic periodic paralysisL J Ptáĉek, R Tawil, R C Griggs, et al.
Cell|June 17, 1994
Dihydropyridine receptor mutations cause hypokalemic periodic paralysisL J Ptácek, R Tawil, R C Griggs, et al.
The American Journal of Cardiology|November 1, 1982
Comparison of oral propranolol and verapamil for combined systemic hypertension and angina pectoris. A placebo-controlled double-blind randomized crossover trialW H Frishman, N A Klein, P Klein, et al.
Pageof 4

Showing results (21-30 of 40) with videos related to

Sort By:
Pageof 4
Neurology|October 24, 2001
Randomized, double-blind, placebo-controlled trial of albuterol in facioscapulohumeral dystrophyJ T Kissel, M P McDermott, J R Mendell, et al.
Annals of Neurology|June 1, 1996
Evidence for anticipation and association of deletion size with severity in facioscapulohumeral muscular dystrophy. The FSH-DY GroupR Tawil, J Forrester, R C Griggs, et al.
Annals of Neurology|March 1, 1994
Andersen's syndrome: potassium-sensitive periodic paralysis, ventricular ectopy, and dysmorphic featuresR Tawil, L J Ptacek, S G Pavlakis, et al.
Neurology|May 22, 1998
Pilot trial of albuterol in facioscapulohumeral muscular dystrophy. FSH-DY GroupJ T Kissel, M P McDermott, R Natarajan, et al.
Cell|December 9, 1991
Identification of a mutation in the gene causing hyperkalemic periodic paralysisL J Ptácek, A L George, R C Griggs, et al.
Nature Genetics|June 1, 1993
Mapping the facioscapulohumeral muscular dystrophy gene is complicated by chromsome 4q35 recombination eventsB Weiffenbach, J Dubois, D Storvick, et al.
Brain : a Journal of Neurology|October 1, 2005
The primary periodic paralyses: diagnosis, pathogenesis and treatmentS L Venance, S C Cannon, D Fialho, et al.
Neurology|August 1, 1994
Sodium channel mutations in acetazolamide-responsive myotonia congenita, paramyotonia congenita, and hyperkalemic periodic paralysisL J Ptáĉek, R Tawil, R C Griggs, et al.
Cell|June 17, 1994
Dihydropyridine receptor mutations cause hypokalemic periodic paralysisL J Ptácek, R Tawil, R C Griggs, et al.
The American Journal of Cardiology|November 1, 1982
Comparison of oral propranolol and verapamil for combined systemic hypertension and angina pectoris. A placebo-controlled double-blind randomized crossover trialW H Frishman, N A Klein, P Klein, et al.
Pageof 4